Citadel Advisors
SWAV

Citadel Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Citadel Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,800
Closed -$10.4M – 15778
2024
Q1 		$10.4M Sell
31,800
-10,700
-25% -$2.63M ﹤0.01% 2911
2023
Q4 		$8.1M Buy
42,500
+1,600
+4% +$302K ﹤0.01% 3125
2023
Q3 		$8.14M Sell
40,900
-10,200
-20% -$2.41M ﹤0.01% 2946
2023
Q2 		$14.6M Buy
51,100
+14,200
+38% +$3.94M ﹤0.01% 2210
2023
Q1 		$8M Sell
36,900
-23,400
-39% -$4.56M ﹤0.01% 3106
2022
Q4 		$12.4M Sell
60,300
-41,100
-41% -$10.4M ﹤0.01% 2514
2022
Q3 		$28.2M Buy
101,400
+28,300
+39% +$7.2M 0.01% 1541
2022
Q2 		$14M Buy
73,100
+23,400
+47% +$4.13M ﹤0.01% 2263
2022
Q1 		$10.3M Sell
49,700
-25,500
-34% -$4.2M ﹤0.01% 2900
2021
Q4 		$13.4M Sell
75,200
-8,600
-10% -$1.7M ﹤0.01% 2581
2021
Q3 		$17.3M Buy
83,800
+22,300
+36% +$4.38M ﹤0.01% 2221
2021
Q2 		$11.7M Buy
61,500
+5,700
+10% +$933K ﹤0.01% 2836
2021
Q1 		$7.27M Sell
55,800
-41,300
-43% -$4.95M ﹤0.01% 3502
2020
Q4 		$10.1M Buy
97,100
+56,200
+137% +$4.87M ﹤0.01% 2635
2020
Q3 		$3.1M Sell
40,900
-7,700
-16% -$437K ﹤0.01% 3933
2020
Q2 		$2.3M Sell
48,600
-1,800
-4% -$74.2K ﹤0.01% 4324
2020
Q1 		$1.67M Buy
50,400
+39,500
+362% +$1.57M ﹤0.01% 4432
2019
Q4 		$479K Buy
+10,900
New +$403K ﹤0.01% 6877

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citadel Advisors's SWAV Position: Q2 2024 in Review

Citadel Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 495,358 shares — an estimated $161M sold.

Citadel Advisors first reported a position in SWAV in Q1 2019 and held it in 20 quarters. The position peaked at $170M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Citadel Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 495,358 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $161M.
  • Citadel Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
  • Citadel Advisors's Shockwave Medical, Inc. Common Stock position peaked at $170M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.